| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medicine, Cedars-Sinai Medical Center, University of California Los Angeles Los Angeles, California 90048
Correspondence: Address requests for reprints to: Mayer B. Davidson, M.D., Division of Endocrinology, Room 1735, 8700 Beverly Boulevard, Cedars-Sinai Medical Center, Los Angeles, California 90048.
Abstract
Introduction: APPROXIMATELY 60 yr ago, Houssay and his colleagues (1) described hypersensitivity to insulin in hypophysectomized (hypox) animals. Further work documented a primary effect of GH in this phenomenon (1). Over the ensuing years, numerous investigators have sought to define the role of GH in carbohydrate and lipid metabolism. Unfortunately, no unified picture has emerged. Both insulin-like and antiinsulin-like effects have been documented, although the physiological significance of the former is uncertain. Major controversies surround the relationship between structure and function of the GH molecule. Indeed, some believe that most of the reported effects of GH are due to contaminants in the hormone preparation. With two exceptions (2, 3), reviews in this area (4–10) have focused mainly on the author's own work in a circumscribed field; e.g. in vivo effects after GH administration (6, 7, 9), tissue effects in vitro (5, 7), or effects on lipolysis (4, 8,10). Furthermore, these reviews were published more than 10 yr ago.
This article has been cited by other articles:
![]() |
M. H. Vickers, S. Gilmour, A. Gertler, B. H. Breier, K. Tunny, M. J. Waters, and P. D. Gluckman 20-kDa placental hGH-V has diminished diabetogenic and lactogenic activities compared with 22-kDa hGH-N while retaining antilipogenic activity Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E629 - E637. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, G. Lin, J. S. Huo, D. Barney, Z. Wang, T. Livshiz, D. J. States, Z. S. Qin, and J. Schwartz Computational and Functional Analysis of Growth Hormone (GH)-Regulated Genes Identifies the Transcriptional Repressor B-Cell Lymphoma 6 (Bc16) as a Participant in GH-Regulated Transcription Endocrinology, August 1, 2009; 150(8): 3645 - 3654. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bielohuby, J. Roemmler, J. Manolopoulou, I. Johnsen, M. Sawitzky, J. Schopohl, M. Reincke, E. Wolf, A. Hoeflich, and M. Bidlingmaier Chronic Growth Hormone Excess Is Associated with Increased Aldosterone: A Study in Patients with Acromegaly and in Growth Hormone Transgenic Mice Experimental Biology and Medicine, August 1, 2009; 234(8): 1002 - 1009. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. de Castro Barbosa, J. E. Nicoletti de Carvalho, L. Lourenco Poyares, S. Bordin, U. Fabres Machado, and M. T. Nunes Potential Role of Growth Hormone in Impairment of Insulin Signaling in Skeletal Muscle, Adipose Tissue, and Liver of Rats Chronically Treated with Arginine Endocrinology, May 1, 2009; 150(5): 2080 - 2086. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Moller and J. O. L. Jorgensen Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects Endocr. Rev., April 1, 2009; 30(2): 152 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G Miquet, L. Gonzalez, M. N Matos, C. E Hansen, A. Louis, A. Bartke, D. Turyn, and A. I Sotelo Transgenic mice overexpressing GH exhibit hepatic upregulation of GH-signaling mediators involved in cell proliferation J. Endocrinol., August 1, 2008; 198(2): 317 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Audi, A. Carrascosa, C. Esteban, M. Fernandez-Cancio, P. Andaluz, D. Yeste, R. Espadero, M. L. Granada, H. Wollmann, L. Fryklund, et al. The exon 3-deleted/full-length Growth Hormone Receptor Polymorphism Does Not Influence the Effect of Puberty or Growth Hormone Therapy on Glucose Homeostasis in Short Non-Growth Hormone-Deficient Small-for-Gestational-Age Children: Results from a Two-Year Controlled Prospective Study J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2709 - 2715. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Short, N. Moller, M. L. Bigelow, J. Coenen-Schimke, and K. S. Nair Enhancement of Muscle Mitochondrial Function by Growth Hormone J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 597 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. van den Eijnden and G. J. Strous Autocrine Growth Hormone: Effects on Growth Hormone Receptor Trafficking and Signaling Mol. Endocrinol., November 1, 2007; 21(11): 2832 - 2846. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gibney, M.-L. Healy, and P. H. Sonksen The Growth Hormone/Insulin-Like Growth Factor-I Axis in Exercise and Sport Endocr. Rev., October 1, 2007; 28(6): 603 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, M. M. Masternak, K. A. Al-Regaiey, and A. Bartke Adipocytokines and the Regulation of Lipid Metabolism in Growth Hormone Transgenic and Calorie-Restricted Mice Endocrinology, June 1, 2007; 148(6): 2845 - 2853. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. A. White, A. A. Coulter, T. K. Miles, and J. M. Stephens The STAT5A-Mediated Induction of Pyruvate Dehydrogenase Kinase 4 Expression by Prolactin or Growth Hormone in Adipocytes Diabetes, June 1, 2007; 56(6): 1623 - 1629. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. del Rincon, K. Iida, B. D. Gaylinn, C. E. McCurdy, J. W. Leitner, L. A. Barbour, J. J. Kopchick, J. E. Friedman, B. Draznin, and M. O. Thorner Growth Hormone Regulation of p85{alpha} Expression and Phosphoinositide 3-Kinase Activity in Adipose Tissue: Mechanism for Growth Hormone-Mediated Insulin Resistance Diabetes, June 1, 2007; 56(6): 1638 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Vickers, P. L. Hofman, P. D. Gluckman, P. E. Lobie, and W. S. Cutfield Combination therapy with acipimox enhances the effect of growth hormone treatment on linear body growth in the normal and small-for-gestational-age rat Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1212 - E1219. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cho, M. Ariga, Y. Uchijima, K. Kimura, J.-Y. Rho, Y. Furuhata, F. Hakuno, K. Yamanouchi, M. Nishihara, and S.-I. Takahashi The Novel Roles of Liver for Compensation of Insulin Resistance in Human Growth Hormone Transgenic Rats Endocrinology, November 1, 2006; 147(11): 5374 - 5384. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L Rise, S. E Douglas, D. Sakhrani, J. Williams, K V. Ewart, M. Rise, W. S Davidson, B. F Koop, and R. H Devlin Multiple microarray platforms utilized for hepatic gene expression profiling of GH transgenic coho salmon with and without ration restriction. J. Mol. Endocrinol., October 1, 2006; 37(2): 259 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Huo, R. C. McEachin, T. X. Cui, N. K. Duggal, T. Hai, D. J. States, and J. Schwartz Profiles of Growth Hormone (GH)-regulated Genes Reveal Time-dependent Responses and Identify a Mechanism for Regulation of Activating Transcription Factor 3 By GH J. Biol. Chem., February 17, 2006; 281(7): 4132 - 4141. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Flores-Morales, C. J. Greenhalgh, G. Norstedt, and E. Rico-Bautista Negative Regulation of Growth Hormone Receptor Signaling Mol. Endocrinol., February 1, 2006; 20(2): 241 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Healy, J. Gibney, C. Pentecost, P. Croos, D. L. Russell-Jones, P. H. Sonksen, and A. M. Umpleby Effects of High-Dose Growth Hormone on Glucose and Glycerol Metabolism at Rest and during Exercise in Endurance-Trained Athletes J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 320 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Miquet, A. I. Sotelo, A. Bartke, and D. Turyn Desensitization of the JAK2/STAT5 GH signaling pathway associated with increased CIS protein content in liver of pregnant mice Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E600 - E607. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gibney, G. Johannsson, K.-C. Leung, and K. K. Y. Ho Comparison of the Metabolic Effects of Raloxifene and Oral Estrogen in Postmenopausal and Growth Hormone-Deficient Women J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3897 - 3903. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rico-Bautista, C. J. Greenhalgh, P. Tollet-Egnell, D. J. Hilton, W. S. Alexander, G. Norstedt, and A. Flores-Morales Suppressor of Cytokine Signaling-2 Deficiency Induces Molecular and Metabolic Changes that Partially Overlap with Growth Hormone-Dependent Effects Mol. Endocrinol., March 1, 2005; 19(3): 781 - 793. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jessen, C. B. Djurhuus, J. O. L. Jorgensen, L. S. Jensen, N. Moller, S. Lund, and O. Schmitz Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E194 - E199. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ameen, D. Linden, B.-M. Larsson, A. Mode, A. Holmang, and J. Oscarsson Effects of gender and GH secretory pattern on sterol regulatory element-binding protein-1c and its target genes in rat liver Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1039 - E1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hayakawa, Y. Shimazaki, T. Tsushima, Y. Kato, K. Takano, K. Chihara, A. Shimatsu, and M. Irie Metabolic Effects of 20-Kilodalton Human Growth Hormone (20K-hGH) for Adults with Growth Hormone Deficiency: Results of an Exploratory Uncontrolled Multicenter Clinical Trial of 20K-hGH J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1562 - 1571. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tollet-Egnell, P. Parini, N. Stahlberg, I. Lonnstedt, N. H. Lee, M. Rudling, A. Flores-Morales, and G. Norstedt Growth hormone-mediated alteration of fuel metabolism in the aged rat as determined from transcript profiles Physiol Genomics, January 15, 2004; 16(2): 261 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Healy, J. Gibney, D. L. Russell-Jones, C. Pentecost, P. Croos, P. H. Sonksen, and A. M. Umpleby High Dose Growth Hormone Exerts an Anabolic Effect at Rest and during Exercise in Endurance-Trained Athletes J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5221 - 5226. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Haluzik, S. Yakar, O. Gavrilova, J. Setser, Y. Boisclair, and D. LeRoith Insulin Resistance in the Liver-Specific IGF-1 Gene-Deleted Mouse Is Abrogated by Deletion of the Acid-Labile Subunit of the IGF-Binding Protein-3 Complex: Relative Roles of Growth Hormone and IGF-1 in Insulin Resistance Diabetes, October 1, 2003; 52(10): 2483 - 2489. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Coschigano, A. N. Holland, M. E. Riders, E. O. List, A. Flyvbjerg, and J. J. Kopchick Deletion, But Not Antagonism, of the Mouse Growth Hormone Receptor Results in Severely Decreased Body Weights, Insulin, and Insulin-Like Growth Factor I Levels and Increased Life Span Endocrinology, September 1, 2003; 144(9): 3799 - 3810. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Olsson, M. Bohlooly-Y, O. Brusehed, O. G. P. Isaksson, B. Ahren, S.-O. Olofsson, J. Oscarsson, and J. Tornell Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genes Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E504 - E511. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gent, M. van den Eijnden, P. van Kerkhof, and G. J. Strous Dimerization and Signal Transduction of the Growth Hormone Receptor Mol. Endocrinol., May 1, 2003; 17(5): 967 - 975. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gibney, M. L. Healy, M. Stolinski, S. B. Bowes, C. Pentecost, L. Breen, C. McMillan, D. L. Russell-Jones, P. H. Sonksen, and A. M. Umpleby Effect of Growth Hormone (GH) on Glycerol and Free Fatty Acid Metabolism during Exhaustive Exercise in GH-Deficient Adults J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1792 - 1797. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Leung, N. Doyle, M. Ballesteros, K. Sjogren, C. K. W. Watts, T. H. Low, G. M. Leong, R. J. M. Ross, and K. K. Y. Ho Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2 PNAS, February 4, 2003; 100(3): 1016 - 1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. van Pareren, P. Mulder, M. Houdijk, M. Jansen, M. Reeser, and A. Hokken-Koelega Effect of Discontinuation of Growth Hormone Treatment on Risk Factors for Cardiovascular Disease in Adolescents Born Small for Gestational Age J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 347 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Gevers, N. Loveridge, and I. C. A. F. Robinson Bone Marrow Adipocytes: A Neglected Target Tissue for Growth Hormone Endocrinology, October 1, 2002; 143(10): 4065 - 4073. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Obeidat, M. G. Thomas, D. M. Hallford, D. H. Keisler, M. K. Petersen, W. D. Bryant, M. D. Garcia, L. Narro, and R. Lopez Metabolic characteristics of multiparous Angus and Brahman cows grazing in the Chihuahuan Desert J Anim Sci, September 1, 2002; 80(9): 2223 - 2233. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yuen, K. Ong, S. Husbands, P. Chatelain, L. Fryklund, P. Gluckman, M. Ranke, D. Cook, R. Rosenfeld, J. Wass, et al. The Effects of Short-Term Administration of Two Low Doses Versus the Standard GH Replacement Dose on Insulin Sensitivity and Fasting Glucose Levels in Young Healthy Adults J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 1989 - 1995. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sesmilo, W. P. Fairfield, L. Katznelson, K. Pulaski, P. U. Freda, V. Bonert, E. Dimaraki, S. Stavrou, M. L. Vance, D. Hayden, et al. Cardiovascular Risk Factors in Acromegaly before and after Normalization of Serum IGF-I Levels with the GH Antagonist Pegvisomant J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1692 - 1699. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. P. Dominici and D. Turyn Growth Hormone-Induced Alterations in the Insulin-Signaling System Experimental Biology and Medicine, March 1, 2002; 227(3): 149 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. McConnell, A. B. Atkinson, C. Ennis, D. R. Hadden, D. R. McCance, B. Sheridan, and P. M. Bell The Effects on Insulin Action in Adult Hypopituitarism of Recombinant Human GH Therapy Individually Titrated for Six Months J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5342 - 5347. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Fitts, R. M. Klein, and C. A. Powers Estrogen and Tamoxifen Interplay with T3 in Male Rats: Pharmacologically Distinct Classes of Estrogen Responses Affecting Growth, Bone, and Lipid Metabolism, and Their Relation to Serum GH and IGF-I Endocrinology, October 1, 2001; 142(10): 4223 - 4235. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Sadowski, T. T. Wheeler, L.-H. Wang, and H. B. Sadowski GH Regulation of IGF-I and Suppressor of Cytokine Signaling Gene Expression in C2C12 Skeletal Muscle Cells Endocrinology, September 1, 2001; 142(9): 3890 - 3900. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bartke, K. Coschigano, J. Kopchick, V. Chandrashekar, J. Mattison, B. Kinney, and S. Hauck Genes That Prolong Life: Relationships of Growth Hormone and Growth to Aging and Life Span J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2001; 56(8): B340 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Flores-Morales, N. Stahlberg, P. Tollet-Egnell, J. Lundeberg, R. L. Malek, J. Quackenbush, N. H. Lee, and G. Norstedt Microarray Analysis of the in Vivo Effects of Hypophysectomy and Growth Hormone Treatment on Gene Expression in the Rat Endocrinology, July 1, 2001; 142(7): 3163 - 3176. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tollet-Egnell, A. Flores-Morales, N. Ståhlberg, R. L. Malek, N. Lee, and G. Norstedt Gene Expression Profile of the Aging Process in Rat Liver: Normalizing Effects of Growth Hormone Replacement Mol. Endocrinol., February 1, 2001; 15(2): 308 - 318. [Abstract] [Full Text] |
||||
![]() |
R. Heptulla, A. Smitten, B. Teague, W. V. Tamborlane, Y.-Z. Ma, and S. Caprio Temporal Patterns of Circulating Leptin Levels in Lean and Obese Adolescents: Relationships to Insulin, Growth Hormone, and Free Fatty Acids Rhythmicity J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 90 - 96. [Abstract] [Full Text] |
||||
![]() |
K.-C. Leung, N. Doyle, M. Ballesteros, M. J. Waters, and K. K. Y. Ho Insulin Regulation of Human Hepatic Growth Hormone Receptors: Divergent Effects on Biosynthesis and Surface Translocation J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4712 - 4720. [Abstract] [Full Text] |
||||
![]() |
D. Linden, A. Sjoberg, L. Asp, L. Carlsson, and J. Oscarsson Direct effects of growth hormone on production and secretion of apolipoprotein B from rat hepatocytes Am J Physiol Endocrinol Metab, December 1, 2000; 279(6): E1335 - E1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nørrelund, N. Vahl, A. Juul, N. Møller, K. G. M. M. Alberti, N. E. Skakkebæk, J. S. Christiansen, and J. O. L. Jørgensen Continuation of Growth Hormone (GH) Therapy in GH-Deficient Patients during Transition from Childhood to Adulthood: Impact on Insulin Sensitivity and Substrate Metabolism J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1912 - 1917. [Abstract] [Full Text] |
||||
![]() |
H. D. McIntyre, R. Serek, D. I. Crane, T. Veveris-Lowe, A. Parry, S. Johnson, K. C. Leung, K. K. Y. Ho, M. Bougoussa, G. Hennen, et al. Placental Growth Hormone (GH), GH-Binding Protein, and Insulin-Like Growth Factor Axis in Normal, Growth-Retarded, and Diabetic Pregnancies: Correlations with Fetal Growth J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1143 - 1150. [Abstract] [Full Text] |
||||
![]() |
J. K. Kim, C. S. Choi, and J. H. Youn Acute effect of growth hormone to induce peripheral insulin resistance is independent of FFA and insulin levels in rats Am J Physiol Endocrinol Metab, October 1, 1999; 277(4): E742 - E749. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. P. Dominici, D. Cifone, A. Bartke, and D. Turyn Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH-transgenic mice Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E447 - E454. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tollet-Egnell, A. Flores-Morales, A. Stavréus-Evers, L. Sahlin, and G. Norstedt Growth Hormone Regulation of SOCS-2, SOCS-3, and CIS Messenger Ribonucleic Acid Expression in the Rat Endocrinology, August 1, 1999; 140(8): 3693 - 3704. [Abstract] [Full Text] |
||||
![]() |
P. M. Piatti, L. D. Monti, A. Caumo, M. Conti, F. Magni, M. Galli-Kienle, E. Fochesato, A. Pizzini, L. Baldi, G. Valsecchi, et al. Mediation of the Hepatic Effects of Growth Hormone by Its Lipolytic Activity J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1658 - 1663. [Abstract] [Full Text] |
||||
![]() |
P. Parini, B. Angelin, and M. Rudling Cholesterol and Lipoprotein Metabolism in Aging : Reversal of Hypercholesterolemia by Growth Hormone Treatment in Old Rats Arterioscler Thromb Vasc Biol, April 1, 1999; 19(4): 832 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Maffei, N. Sicolo, and M. Plebani Lipoprotein(a) in Acromegaly Ann Intern Med, March 16, 1999; 130(6): 537 - 538. [Full Text] [PDF] |
||||
![]() |
A. C. P. Thirone, C. R. O. Carvalho, and M. J. A. Saad Growth Hormone Stimulates the Tyrosine Kinase Activity of JAK2 and Induces Tyrosine Phosphorylation of Insulin Receptor Substrates and Shc in Rat Tissues Endocrinology, January 1, 1999; 140(1): 55 - 62. [Abstract] [Full Text] |
||||
![]() |
M. Miyakawa, T. Tsushima, H. Murakami, O. Isozaki, H. Demura, and T. Tanaka Effect of Growth Hormone (GH) on Serum Concentrations of Leptin: Study in Patients with Acromegaly and GH Deficiency J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3476 - 3479. [Abstract] [Full Text] |
||||
![]() |
P. Saenger, K. M. Attie, J. DiMartino-Nardi, R. Hintz, L. Frahm, and J. W. Frane Metabolic Consequences of 5-Year Growth Hormone (GH) Therapy in Children Treated with GH for Idiopathic Short Stature J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3115 - 3120. [Abstract] [Full Text] |
||||
![]() |
L. H. Hansen, B. Madsen, B. Teisner, J. H. Nielsen, and N. Billestrup Characterization of the Inhibitory Effect of Growth Hormone on Primary Preadipocyte Differentiation Mol. Endocrinol., August 1, 1998; 12(8): 1140 - 1149. [Abstract] [Full Text] |
||||
![]() |
A. Ikeda, K.-T. Chang, Y. Matsumoto, Y. Furuhata, M. Nishihara, F. Sasaki, and M. Takahashi Obesity and Insulin Resistance in Human Growth Hormone Transgenic Rats Endocrinology, July 1, 1998; 139(7): 3057 - 3063. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. ETHERTON and D. E. BAUMAN Biology of Somatotropin in Growth and Lactation of Domestic Animals Physiol Rev, July 1, 1998; 78(3): 745 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Carlsson, I. Nilsson, and J. Oscarsson Hormonal Regulation of Liver Fatty Acid-Binding Protein in Vivo and in Vitro: Effects of Growth Hormone and Insulin Endocrinology, June 1, 1998; 139(6): 2699 - 2709. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fernandez, A. Flores-Morales, O. Lahuna, D. Sliva, G. Norstedt, L.-A. Haldosen, A. Mode, and J.-A. Gustafsson Desensitization of the Growth Hormone-Induced Janus Kinase 2 (Jak 2)/Signal Transducer and Activator of Transcription 5 (Stat5)-Signaling Pathway Requires Protein Synthesis and Phospholipase C Endocrinology, April 1, 1998; 139(4): 1815 - 1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-W. L. Gong, D. J. Meyer, J. Liao, C. L. Hodge, G. S. Campbell, X. Wang, N. Billestrup, C. Carter-Su, and J. Schwartz Regulation of Glucose Transport and c-fos and egr-1 Expression in Cells with Mutated or Endogenous Growth Hormone Receptors Endocrinology, April 1, 1998; 139(4): 1863 - 1871. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Herman-Bonert, M. Seliverstov, and S. Melmed Pregnancy in Acromegaly: Successful Therapeutic Outcome J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 727 - 731. [Full Text] |
||||
![]() |
P. V. Carroll, E. R. Christ the members of Growth Hormone Research Soci, B. A. Bengtsson, L. Carlsson, J. S. Christiansen, D. Clemmons, R. Hintz, K. Ho, Z. Laron, P. Sizonenko, et al. Growth Hormone Deficiency in Adulthood and the Effects of Growth Hormone Replacement: A Review J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 382 - 395. [Abstract] [Full Text] |
||||
![]() |
K.-C. Leung and K. K. Y. Ho Stimulation of Mitochondrial Fatty Acid Oxidation by Growth Hormone in Human Fibroblasts J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4208 - 4213. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Harding, P. C. Evans, and P. D. Gluckman Maternal Growth Hormone Treatment Increases Placental Diffusion Capacity But Not Fetal or Placental Growth in Sheep Endocrinology, December 1, 1997; 138(12): 5352 - 5358. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Lahuna, L. Fernandez, H. Karlsson, D. Maiter, F. P. Lemaigre, G. G. Rousseau, J.-A. Gustafsson, and A. Mode Expression of hepatocyte nuclear factor 6 in rat liver is sex-dependent and regulated by growth hormone PNAS, November 11, 1997; 94(23): 12309 - 12313. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hettiarachchi, S. Chalkley, S. M. Furler, Y.-S. Choong, M. Heller, G. J. S. Cooper, and E. W. Kraegen Rat amylin-(8---37) enhances insulin action and alters lipid metabolism in normal and insulin-resistant rats Am J Physiol Endocrinol Metab, November 1, 1997; 273(5): E859 - E867. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-C. Leung, M. J. Waters, I. Markus, W. R. Baumbach, and K. K. Y. Ho Insulin and insulin-like growth factor-I acutely inhibit surface translocation of growth hormone receptors in osteoblasts: A novel mechanism of growth hormone receptor regulation PNAS, October 14, 1997; 94(21): 11381 - 11386. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Arslanian and C. Suprasongsin Testosterone Treatment in Adolescents with Delayed Puberty: Changes in Body Composition, Protein, Fat, and Glucose Metabolism J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3213 - 3220. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Smit, J. A. VanderKuur, A. Stimage, Y. Han, G. Luo, L.-y. Yu-Lee, J. Schwartz, and C. Carter-Su Growth Hormone-Induced Tyrosyl Phosphorylation and Deoxyribonucleic Acid Binding Activity of Stat5A and Stat5B Endocrinology, August 1, 1997; 138(8): 3426 - 3434. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Flogstad, J. Halse, S. Bakke, I. Lancranjan, P. Marbach, Ch. Bruns, and J. Jervell Sandostatin LAR in Acromegalic Patients: Long Term Treatment J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 23 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
Committee on Drugs and Committee on Bioethics Considerations Related to the Use of Recombinant Human Growth Hormone in Children Pediatrics, January 1, 1997; 99(1): 122 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Argetsinger, G. W. Hsu, M. G. Myers Jr., N. Billestrup, M. F. White, and C. Carter-Su Growth Hormone, Interferon-[IMAGE], and Leukemia Inhibitory Factor Promoted Tyrosyl Phosphorylation of Insulin Receptor Substrate-1 J. Biol. Chem., June 16, 1995; 270(24): 14685 - 14692. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. VanderKuur, G. Allevato, N. Billestrup, G. Norstedt, and C. Carter-Su Growth Hormone-promoted Tyrosyl Phosphorylation of SHC Proteins and SHC Association with Grb2 J. Biol. Chem., March 31, 1995; 270(13): 7587 - 7593. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |